GENEVA – Cardiometabolic diseases, a group of non-communicable diseases (NCDs) including cardiovascular disease, stroke, diabetes, and non-alcoholic fatty liver disease, are on the rise globally, threatening life expectancy gains and burdening vulnerable economies with excess healthcare costs. These diseases already contribute to over 30% of global deaths each year. With one billion people now living […] Continue reading ->
Almost 70% of the 4.2 million deaths attributed to ambient (outdoor) air pollution in 2019 were caused by cardiovascular diseases, notably ischaemic heart disease (1.9 million deaths) and stroke (900,000 deaths), according to a new report by the World Heart Federation (WHF). The report highlights the outsized impacts air pollution is having on the worldwide […] Continue reading ->
The rising cost of healthcare is one of the most significant burdens on countries, especially low- and middle-income countries. Research has shown that self-care can be critical in reducing unnecessary expenses for healthcare systems. Global self-care activities generate substantial monetary and healthcare workforce savings, totalling at least approximately $119 billion per year, according to a […] Continue reading ->
A $3-million “educational” deal between tobacco giant Philip Morris International (PMI) and Medscape, a medical education provider for healthcare professionals, has been abandoned after the BMJ and The Examination exposed it last month. The deal involved a PMI grant to Medscape to fund continuing medical education (CME) accredited courses on smoking cessation for doctors and […] Continue reading ->
With Gaza’s Rafah crossing into Egypt closed by an advancing Israeli incursion, and Israel’s Kerem Shalom crossing shut since last Sunday’s Hamas missile attack, Gaza hospitals have only about three days left of fuel and medical supplies, said WHO Director General Dr Tedros Adhanom Ghebreyesus Wednesday.     The global health agency is making contingency plans for […] Continue reading ->
Insulin pens are more affordable and preferred by diabetics but they are available almost exclusively in high-income countries due to gross overpricing, according to a report by Médecins Sans Frontières (MSF) and T1International, a British NGO fighting for equal treatment access for people with diabetes type 1. The research was presented on Wednesday, ahead of […] Continue reading ->